Jacobus Wealth Management’s AstraZeneca AZN Stock Holding History

Jacobus Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,249	Closed	-$127K	–	216
2016 Q1	$127K	Hold	2,249	–	–	0.04%	241
2015 Q4	$153K	Sell	2,249 -200	-8%	-$13.1K	0.04%	230
2015 Q3	$156K	Hold	2,449	–	–	0.05%	231
2015 Q2	$156K	Hold	2,449	–	–	0.04%	242
2015 Q1	$168K	Hold	2,449	–	–	0.04%	230
2014 Q4	$172K	Hold	2,449	–	–	0.04%	220
2014 Q3	$175K	Hold	2,449	–	–	0.05%	219
2014 Q2	$182K	Hold	2,449	–	–	0.05%	224
2014 Q1	$159K	Hold	2,449	–	–	0.04%	244
2013 Q4	$145K	Buy	+2,449	New	+$133K	0.04%	247

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jacobus Wealth Management's AZN Position: Q2 2016 in Review

Jacobus Wealth Management sold out of AstraZeneca (AZN) in Q2 2016, closing a stake of 2,249 shares — an estimated $127K sold.

Jacobus Wealth Management first reported a position in AZN in Q4 2013 and held it in 10 quarters. The position peaked at $182K in Q2 2014. 398 funds tracked by Wall St. Rank hold AZN as of Q2 2016.

Jacobus Wealth Management reported no remaining AstraZeneca position as of Q2 2016 after selling out during the quarter.
Jacobus Wealth Management sold 2,249 AstraZeneca shares in Q2 2016, an estimated $127K.
Jacobus Wealth Management first reported a position in AstraZeneca in Q4 2013 and held it in 10 quarters.
Jacobus Wealth Management's AstraZeneca position peaked at $182K in Q2 2014.
398 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2016.

Based on Jacobus Wealth Management's 13F filing for Q2 2016, filed 5 Aug 2016.